Pharmaceutical, Biotech, and Healthcare Industry News
Recent legislative changes are having a profound impact on the pharmaceutical industry, influencing everything from drug pricing and development to market access and patient care. Understanding these changes is crucial for industry stakeholders to navigate the evolving landscape effectively. Key Legislative Areas Affecting Pharma Impact...
Real-World Data (RWD) is revolutionizing the pharmaceutical industry, offering unprecedented insights into drug efficacy, safety, and patient outcomes outside the controlled environment of clinical trials. This wealth of information is transforming how drugs are developed, approved, and monitored post-market. Understanding Real-World Data in Pharmaceuticals Real-World...
Diversity in clinical trials is not just a matter of equity—it’s crucial for developing safe and effective treatments for all populations. Historically, clinical trials have often lacked representation from minority groups, leading to gaps in understanding how drugs affect different populations. The Importance of Diversity...
The Food and Drug Administration withdrew its emergency use authorizations the two antiviral drugs promoted by President Trump, despite concerns surrounding their effectiveness and safety.
The FDA has approved the very first treatment for COVID-19, and the drugmaker has donated their “entire supply.”
On October 24th, President Trump signed a package of bills designed to confront and combat the nation’s opioid epidemic. On November 2nd, the FDA approved Dsuvia.
